Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Real-time Estimate Tradegate 08:37:17 2024-06-24 am EDT 5-day change 1st Jan Change
26.6 EUR +2.30% Intraday chart for Bayer AG +1.76% -20.93%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Bayer and Solynta Collaborate to Advance True Potato Seed in Smallholder Markets CI
Global markets live: Vodafone, Bayer, Apple, Microsoft, Qualcomm... Our Logo
Bayer's Crop Science Business Developing AI to Kill Weeds MT
Bayer looks to AI to combat herbicide resistance faster RE
Transcript : Bayer Aktiengesellschaft - Special Call
New Bayer short corn variety stands up to high winds, but not over 100 mph RE
South Africa finds high prices, lack of competition in its fresh produce market RE
Economics Minister Habeck travels to China without prominent company representatives RE
Alvotech Enters Commercialization Deal for Eylea Biosimilars with Advanz Pharma MT
Nationwide actions - Trade union increases pressure in chemical industry collective bargaining round DP
German economy minister's China trip features low-key business delegation amid EV clash RE
BAYER : Berenberg remains 'hold', target 30 euros CF
Bayer Targets 10 Blockbuster Product Launches for Crop Sciences MT
Bayer has more confidence in its agricultural pipeline thanks to new products RE
Bayer: ten 'blockbusters' expected in crop protection CF
Bayer to Launch Ten Blockbuster Agriculture Products in the Next Decade DJ
Berenberg rates Bayer a 'Hold' - Target 30 euros DP
BAYER AG : Berenberg remains Neutral ZD
BAYER AG : Barclays sticks Neutral ZD
Restrictions on glyphosate remain in place DP
Archer-Daniels-Midland, Bayer to Expand Regenerative Agriculture Program to Eastern Europe MT
Dpa-AFX Overview: COMPANIES as of 11/06/2024 - 15:15 DP
Bayer: decision in China for lung cancer CF
Bayer's Lung Cancer Drug Gets Breakthrough Therapy Status in China DJ
Bayer: working with PAPACKS on sustainable packaging CF
Chart Bayer AG
More charts
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
26 EUR
Average target price
36.18 EUR
Spread / Average Target
+39.16%
Consensus
  1. Stock Market
  2. Equities
  3. BAYN Stock
  4. News Bayer AG
  5. Bayer Launches First-in-Human Study of Prostate Cancer Drug Candidate